The Technical Analyst
Select Language :
Nymox Pharmaceutical Corp [NYMX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Nymox Pharmaceutical Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Nymox Pharmaceutical Corp is listed at the  Exchange

-0.05% $0.200

America/New_York / 6 jul 2023 @ 16:00


Nymox Pharmaceutical Corp: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 18.24 mill
EPS: -0.0700
P/E: -2.86
Earnings Date: May 02, 2023
SharesOutstanding: 91.27 mill
Avg Daily Volume: 0.135 mill
RATING 2023-08-11
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
1/222/223/224/221/232/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.86 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.49x
Company: PE -2.86 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.816 - 1.138

( +/- 16.48%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-04-27 Robinson James George Buy 40 000 Common Stock
2023-04-25 Robinson James George Buy 40 000 Common Stock
2023-04-25 Robinson James George Buy 40 000 Common Stock
2022-05-02 Robinson James George Buy 1 151 515 Warrant
2021-04-22 Robinson James George Buy 200 Common Stock
INSIDER POWER
100.00
Last 100 transactions
Buy: 1 546 252 | Sell: 0

Forecast: 01:40 - $0.744

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.200 (-0.05% )
Volume 0.882 mill
Avg. Vol. 0.135 mill
% of Avg. Vol 654.10 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Nymox Pharmaceutical Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Nymox Pharmaceutical Corp

RSI

Intraday RSI14 chart for Nymox Pharmaceutical Corp

Last 10 Buy & Sell Signals For NYMX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Nymox Pharmaceutical Corp

NYMX

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.

Last 10 Buy Signals

Date Signal @
NOD.OLMar 27 - 08:05NOK85.80
SOON.OLMar 27 - 08:05NOK67.00
ELO.OLMar 27 - 08:05NOK34.00
VEI.OLMar 27 - 08:05NOK118.00
RIVER.OLMar 27 - 08:0527.00
MAS.OLMar 27 - 08:0530.30
NAVA.OLMar 27 - 07:58NOK35.60
CARA.OLMar 27 - 08:05NOK11.52
NOL.OLMar 27 - 08:09NOK9.97
OLT.OLMar 27 - 08:05NOK222.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.